Ted Lamson

Ted Lamson is a co-founder of NeoTract, Inc., bringing over 25 years of experience in medical device development. They initiated their career with the Penn State artificial heart and have since worked on various innovative medical devices, including in interventional cardiology and urology. As the co-inventor of the UroLift treatment, Ted continues to contribute to the field through consulting roles at Teleflex and participation in startup activities. Ted holds a BS in Chemical Engineering from Rensselaer Polytechnic Institute and multiple advanced degrees in Bioengineering from Penn State University.